Clinical Trial

ARTICE® Real Data Collection & Observational Trial, Phase 4 Study

Study acronym: ARTistry
Recruiting
View on ClinicalTrials.gov →
Summary
The objectives of this registry study are to: 1. Record real-life data related to the use of the ARTICE® therapy in sepsis subjects. 2. Further evaluate ARTICE® treatment efficacy. 3. Identify potential sub-groups, assess their risk-benefit- and safety profile. 4. Changes in SOFA score D0 to SOFA Score D7.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-01-28; most recent amendment 2026-07-14.
Trial Details
NCT Number NCT07388628
Lead Sponsor Artcline GmbH
Conditions Sepsis, Septic Shock, Immunoparalysis in Septic Shock
Enrollment 200 participants
Start Date 2025-09-25
Primary Completion 2027-09 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-15